Comparative analysis of core and perfusion lesion volumes between commercially available computed tomography perfusion software.


Journal

European stroke journal
ISSN: 2396-9881
Titre abrégé: Eur Stroke J
Pays: England
ID NLM: 101688446

Informations de publication

Date de publication:
03 2023
Historique:
received: 21 08 2022
accepted: 12 10 2022
medline: 7 4 2023
entrez: 6 4 2023
pubmed: 7 4 2023
Statut: ppublish

Résumé

Computed tomography perfusion (CTP) imaging has become an important tool in evaluating acute recanalization treatment candidates. Large clinical trials have successfully used RAPID automated imaging analysis software for quantifying ischemic core and penumbra, yet other commercially available software vendors are also on the market. We evaluated the possible difference in ischemic core and perfusion lesion volumes and the agreement rate of target mismatch between OLEA, MIStar, and Syngo.Via versus RAPID software in acute recanalization treatment candidates. All consecutive stroke-code patients with baseline CTP RAPID imaging at Helsinki University Hospital during 8/2018-9/2021 were included. Ischemic core was defined as cerebral blood flow <30% than the contralateral hemisphere and within the area of delay time (DT) >3s with MIStar. Perfusion lesion volume was defined as DT > 3 s (MIStar) and T A total of 1606 patients had RAPID perfusion maps, 1222 of which had MIStar, 596 patients had OLEA, and 349 patients had Syngo.Via perfusion maps available. Each software was compared with simultaneously analyzed RAPID software. MIStar showed the smallest core difference compared with RAPID (-2 mL, confidence interval (CI) from -26 to 22), followed by OLEA (2 mL, CI from -33 to 38). Perfusion lesion volume differed least with MIStar (4 mL, CI from -62 to 71) in comparison with RAPID, followed by Syngo.Via (6 mL, CI from -94 to 106). MIStar had the best agreement rate with target mismatch of RAPID followed by OLEA and Syngo.Via. Comparison of RAPID with three other automated imaging analysis software showed variance in ischemic core and perfusion lesion volumes and in target mismatch.

Identifiants

pubmed: 37021148
doi: 10.1177/23969873221135915
pii: 10.1177_23969873221135915
pmc: PMC10069177
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

259-267

Informations de copyright

© European Stroke Organisation 2022.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
Stroke. 2009 Jun;40(6):2046-54
pubmed: 19359641
J Stroke Cerebrovasc Dis. 2022 Jun;31(6):106482
pubmed: 35429702
Neuroradiology. 2021 Oct;63(10):1645-1649
pubmed: 33580356
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
Stroke. 2022 May;53(5):1657-1664
pubmed: 34872342
Stroke. 2020 Mar;51(3):1017-1024
pubmed: 32008460
Stroke. 2011 Jun;42(6):1608-14
pubmed: 21493916
Clin Neuroradiol. 2021 Jun;31(2):499-506
pubmed: 33216157
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
J Neurointerv Surg. 2019 Dec;11(12):1249-1256
pubmed: 31203208
J Stroke Cerebrovasc Dis. 2019 Dec;28(12):104392
pubmed: 31562038
Stroke. 2016 Apr;47(4):1153-8
pubmed: 26965849
Lancet. 2020 Jul 11;396(10244):129-142
pubmed: 32653056
Stroke. 2020 Mar;51(3):1006-1009
pubmed: 31948385
Stroke. 2009 Feb;40(2):469-75
pubmed: 19109547
Curr Treat Options Neurol. 2015 Feb;17(2):332
pubmed: 25619536
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Radiology. 2016 Jun;279(3):876-87
pubmed: 26785041
J Cereb Blood Flow Metab. 2016 Oct;36(10):1780-1789
pubmed: 26661203
Stroke. 2018 Oct;49(10):2345-2352
pubmed: 30355089
J Neurointerv Surg. 2020 Oct;12(10):1028-1032
pubmed: 32424007
Stroke. 2004 Jul;35(7):1652-8
pubmed: 15155964
Lancet. 2019 Jul 13;394(10193):139-147
pubmed: 31128925
Ann Neurol. 2016 Jan;79(1):76-89
pubmed: 26476022
Stroke. 2011 Dec;42(12):3435-40
pubmed: 21980202
Stroke. 2014 Jun;45(6):1727-32
pubmed: 24876260
Int J Stroke. 2018 Aug;13(6):554-567
pubmed: 29543140
Stroke. 2016 Sep;47(9):2311-7
pubmed: 27507864

Auteurs

Olli P Suomalainen (OP)

Department of Neurology, Helsinki University Hospital and Clinical Neurosciences, University of Helsinki, Finland.

Nicolas Martinez-Majander (N)

Department of Neurology, Helsinki University Hospital and Clinical Neurosciences, University of Helsinki, Finland.

Gerli Sibolt (G)

Department of Neurology, Helsinki University Hospital and Clinical Neurosciences, University of Helsinki, Finland.

Katariina Bäcklund (K)

Department of Neurology, Helsinki University Hospital and Clinical Neurosciences, University of Helsinki, Finland.

Juha Järveläinen (J)

Department of Neuroradiology, Helsinki University Hospital and Clinical Neurosciences, University of Helsinki, Finland.

Antti Korvenoja (A)

Department of Neuroradiology, Helsinki University Hospital and Clinical Neurosciences, University of Helsinki, Finland.

Marjaana Tiainen (M)

Department of Neurology, Helsinki University Hospital and Clinical Neurosciences, University of Helsinki, Finland.

Nina Forss (N)

Department of Neurology, Helsinki University Hospital and Clinical Neurosciences, University of Helsinki, Finland.
Department of Neuroscience and Biomedical Engineering, Aalto University, Finland.

Sami Curtze (S)

Department of Neurology, Helsinki University Hospital and Clinical Neurosciences, University of Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH